{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T01:38:05Z","timestamp":1750815485301,"version":"3.37.3"},"reference-count":64,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Office of the Director: Regional Medical Centers","award":["1 OT2 OD026549","1 OT2 OD026554","1 OT2 OD026557","1 OT2 OD026556","1 OT2 OD026550","1 OT2 OD 026552","1 OT2 OD026553","1 OT2 OD026548","1 OT2 OD026551","1 OT2 OD026555","IAA #: AOD 16037"],"award-info":[{"award-number":["1 OT2 OD026549","1 OT2 OD026554","1 OT2 OD026557","1 OT2 OD026556","1 OT2 OD026550","1 OT2 OD 026552","1 OT2 OD026553","1 OT2 OD026548","1 OT2 OD026551","1 OT2 OD026555","IAA #: AOD 16037"]}]},{"name":"Federally Qualified Health Centers","award":["HHSN 263201600085U"],"award-info":[{"award-number":["HHSN 263201600085U"]}]},{"name":"Data and Research Center","award":["5 U2C OD023196","1 U24 OD023121"],"award-info":[{"award-number":["5 U2C OD023196","1 U24 OD023121"]}]},{"name":"Participant Technology Systems Center","award":["1 U24 OD023163"],"award-info":[{"award-number":["1 U24 OD023163"]}]},{"name":"Communications and Engagement","award":["3 OT2 OD023205","3 OT2 OD023206","1 OT2 OD025277","3 OT2 OD025315","1 OT2 OD025337","1 OT2 OD025276"],"award-info":[{"award-number":["3 OT2 OD023205","3 OT2 OD023206","1 OT2 OD025277","3 OT2 OD025315","1 OT2 OD025337","1 OT2 OD025276"]}]},{"name":"Evenings with Genetics Research Program","award":["EWG-23-CE-313"],"award-info":[{"award-number":["EWG-23-CE-313"]}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["1 OT2 OD031932-01"],"award-info":[{"award-number":["1 OT2 OD031932-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>We aim to demonstrate the versatility of the All of Us database as an important source of rare and undiagnosed disease (RUD) data, because of its large size and range of data types.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Materials and Methods<\/jats:title>\n                  <jats:p>We searched the public data browser, electronic health record (EHR), and several surveys to investigate the prevalence, mental health, healthcare access, and other data of select RUDs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Several RUDs have participants in All of Us [eg, 75 of 100 rare infectious diseases (RIDs)]. We generated health-related data for undiagnosed, sickle cell disease (SCD), cystic fibrosis (CF), and infectious (2 diseases) and chronic (4 diseases) disease pools.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Our results highlight the potential value of All of Us with both data breadth and depth to help identify possible solutions for shared and disease-specific biomedical and other problems such as healthcare access, thus enhancing diagnosis, treatment, prevention, and support for the RUD community.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jamia\/ocae241","type":"journal-article","created":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T20:53:21Z","timestamp":1734987201000},"page":"579-585","source":"Crossref","is-referenced-by-count":0,"title":["Descriptive epidemiology demonstrating the <i>All of Us<\/i> database as a versatile resource for the rare and undiagnosed disease community"],"prefix":"10.1093","volume":"32","author":[{"given":"Drenen J","family":"Magee","sequence":"first","affiliation":[{"name":"Department of Biological and Health Sciences, Crown College , St Bonifacius, MN 55375,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sierra","family":"Kicker","sequence":"additional","affiliation":[{"name":"Department of Biological and Health Sciences, Crown College , St Bonifacius, MN 55375,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aeisha","family":"Thomas","sequence":"additional","affiliation":[{"name":"Department of Biological and Health Sciences, Crown College , St Bonifacius, MN 55375,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,12,23]]},"reference":[{"issue":"22","key":"2025021811394227300_ocae241-B1","doi-asserted-by":"publisher","first-page":"15174","DOI":"10.3390\/ijerph192215174","article-title":"Health policies for rare disease patients: a scoping review","volume":"19","author":"Lopes-J\u00fanior","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"2025021811394227300_ocae241-B2","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13023-019-1088-3","article-title":"The DM-scope registry: a rare disease innovative framework bridging the gap between research and medical care","volume":"14","author":"De Antonio","year":"2019","journal-title":"Orphanet J Rare Dis"},{"year":"2024","author":"Advancing Sickle Cell Advocacy Project Inc","key":"2025021811394227300_ocae241-B3"},{"year":"2024","author":"NIH Undiagnosed Diseases Network","key":"2025021811394227300_ocae241-B4"},{"key":"2025021811394227300_ocae241-B5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.evalprogplan.2015.03.006","article-title":"Policy recommendations for rare disease centres of expertise","volume":"52","author":"Syed","year":"2015","journal-title":"Eval Program Plann"},{"year":"2024","author":"NORD Rare Disease Centers of Excellence","key":"2025021811394227300_ocae241-B6"},{"year":"2024","author":"Orphanet","key":"2025021811394227300_ocae241-B7"},{"issue":"1","key":"2025021811394227300_ocae241-B8","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s12967-023-04011-y","article-title":"Precision information extraction for rare disease epidemiology at scale","volume":"21","author":"Kariampuzha","year":"2023","journal-title":"J Transl Med"},{"issue":"1","key":"2025021811394227300_ocae241-B9","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1186\/s12967-023-04183-7","article-title":"Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD)","volume":"21","author":"Pinto e Vairo","year":"2023","journal-title":"J Transl Med"},{"issue":"1","key":"2025021811394227300_ocae241-B10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13023-017-0755-5","article-title":"An overview of the impact of rare disease characteristics on research methodology","volume":"13","author":"Whicher","year":"2018","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2025021811394227300_ocae241-B11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13023-017-0591-7","article-title":"\u201cIt\u2019s not all in my head!\u201d\u2014the complex relationship between rare diseases and mental health problems","volume":"12","author":"Nunn","year":"2017","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2025021811394227300_ocae241-B12","doi-asserted-by":"publisher","first-page":"1028545","DOI":"10.3389\/fpubh.2022.1028545","article-title":"Rare disease emerging as a global public health priority","volume":"10","author":"Chung","year":"2022","journal-title":"Front Public Health"},{"issue":"6","key":"2025021811394227300_ocae241-B13","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.chest.2017.12.018","article-title":"The challenge of rare diseases","volume":"153","author":"Stoller","year":"2018","journal-title":"Chest"},{"issue":"3","key":"2025021811394227300_ocae241-B14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.33590\/emj\/10149519","article-title":"Seeing is believing: invisibility exacerbates inequality for patients living with rare disease","volume":"7","author":"Richards","year":"2022","journal-title":"EMJ"},{"issue":"10","key":"2025021811394227300_ocae241-B15","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s11095-018-2481-7","article-title":"Doing it all\u2014how families are reshaping rare disease research","volume":"35","author":"Ekins","year":"2018","journal-title":"Pharm Res"},{"issue":"1","key":"2025021811394227300_ocae241-B16","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1186\/s13023-023-02892-2","article-title":"Prioritization of research engaged with rare disease stakeholders: a systematic review and thematic analysis","volume":"18","author":"Yoon","year":"2023","journal-title":"Orphanet J Rare Dis"},{"year":"2024","author":"Research Program Strategic Goals","key":"2025021811394227300_ocae241-B17"},{"issue":"4","key":"2025021811394227300_ocae241-B18","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1093\/jamia\/ocad260","article-title":"Comparison of phenomic profiles in the All of Us Research Program against the US general population and the UK Biobank","volume":"31","author":"Zeng","year":"2024","journal-title":"J Am Med Inform Assoc"},{"issue":"1","key":"2025021811394227300_ocae241-B19","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13073-022-01094-y","article-title":"Enhanced rare disease mapping for phenome-wide genetic association in the UK Biobank","volume":"14","author":"Patrick","year":"2022","journal-title":"Genome Med"},{"issue":"7814","key":"2025021811394227300_ocae241-B20","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41586-020-2434-2","article-title":"Whole-genome sequencing of patients with rare diseases in a national health system","volume":"583","author":"Turro","year":"2020","journal-title":"Nature"},{"issue":"3","key":"2025021811394227300_ocae241-B21","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41591-023-02211-z","article-title":"Genetic association analysis of 77,539 genomes reveals rare disease etiologies","volume":"29","author":"Greene","year":"2023","journal-title":"Nat Med"},{"issue":"5","key":"2025021811394227300_ocae241-B22","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s00403-022-02488-z","article-title":"Association of sarcoidosis with psoriasis: a cross-sectional study in the All of Us research program","volume":"315","author":"Murphy","year":"2023","journal-title":"Arch Dermatol Res"},{"year":"2024","author":"Research Hub - Data Browser","key":"2025021811394227300_ocae241-B23"},{"year":"2024","author":"Research Hub - Survey Explorer","key":"2025021811394227300_ocae241-B24"},{"year":"2024","author":"Research Hub - Data Methods","key":"2025021811394227300_ocae241-B25"},{"issue":"2","key":"2025021811394227300_ocae241-B26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/d41573-019-00180-y","article-title":"How many rare diseases are there?","volume":"19","author":"Haendel","year":"2020","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"2025021811394227300_ocae241-B27","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13023-022-02343-4","article-title":"Healthcare access, satisfaction, and health-related quality of life among children and adults with rare diseases","volume":"17","author":"Bogart","year":"2022","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"2025021811394227300_ocae241-B28","doi-asserted-by":"publisher","first-page":"e30089","DOI":"10.1002\/pbc.30089","article-title":"Sickle cell disease and social determinants of health: a scoping review","volume":"70","author":"Khan","year":"2023","journal-title":"Pediatr Blood Cancer"},{"year":"2024","author":"NCATS - Translational Science Principles","key":"2025021811394227300_ocae241-B29"},{"year":"2024","author":"NCATS\u00a0- Our Impact on Rare Diseases","key":"2025021811394227300_ocae241-B30"},{"author":"Network of the National Library of Medicine","key":"2025021811394227300_ocae241-B31"},{"year":"2024","author":"NIH Genetic and Rare Diseases Information Center","key":"2025021811394227300_ocae241-B32"},{"year":"2024","author":"HRSA Recommended Uniform Screening Panel","key":"2025021811394227300_ocae241-B33"},{"year":"2024","author":"Research Hub - Data Sources","key":"2025021811394227300_ocae241-B34"},{"year":"2024","author":"Research Hub - Data Access Tiers","key":"2025021811394227300_ocae241-B35"},{"issue":"36","key":"2025021811394227300_ocae241-B36","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.15585\/mmwr.mm6936a6","article-title":"Infants with congenital disorders identified through newborn screening\u2014United States, 2015\u20132017","volume":"69","author":"Sontag","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"2025021811394227300_ocae241-B37","doi-asserted-by":"publisher","first-page":"15030","DOI":"10.1038\/s41598-023-41868-x","article-title":"Cystic fibrosis-related mortality in the United States from 1999 to 2020: an observational analysis of time trends and disparities","volume":"13","author":"Singh","year":"2023","journal-title":"Sci Rep"},{"issue":"1","key":"2025021811394227300_ocae241-B38","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12913-020-5054-5","article-title":"Prevalence, characteristics, and costs of diagnosed homocystinuria, elevated homocysteine, and phenylketonuria in the United States: a retrospective claims-based comparison","volume":"20","author":"Sellos-Moura","year":"2020","journal-title":"BMC Health Serv Res"},{"issue":"Supplement 1","key":"2025021811394227300_ocae241-B39","doi-asserted-by":"publisher","first-page":"3900","DOI":"10.1182\/blood-2023-189287","article-title":"Estimating sickle cell disease prevalence by state: a model using US-born and foreign-born state-specific population data","volume":"142","author":"Fu","year":"2023","journal-title":"Blood"},{"year":"2024","author":"National Organization for Rare Diseases - Beta Thalassemia","key":"2025021811394227300_ocae241-B40"},{"issue":"1","key":"2025021811394227300_ocae241-B41","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s11205-011-9871-0","article-title":"Social quality: a way to measure the quality of society","volume":"108","author":"Abbott","year":"2012","journal-title":"Soc Indic Res"},{"issue":"2","key":"2025021811394227300_ocae241-B42","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12288-013-0261-4","article-title":"Hydroxyurea in sickle cell disease: drug review","volume":"30","author":"Agrawal","year":"2014","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"3","key":"2025021811394227300_ocae241-B43","doi-asserted-by":"publisher","first-page":"192","DOI":"10.5863\/1551-6776-25.3.192","article-title":"Elexacaftor-tezacaftor-ivacaftor: the first triple-combination cystic fibrosis transmembrane conductance regulator modulating therapy","volume":"25","author":"Ridley","year":"2020","journal-title":"J Pediatr Pharmacol Ther"},{"key":"2025021811394227300_ocae241-B44","doi-asserted-by":"publisher","first-page":"832063","DOI":"10.3389\/fendo.2022.832063","article-title":"Rare disease registries are key to evidence-based personalized medicine: highlighting the European experience","volume":"13","author":"K\u00f6lker","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025021811394227300_ocae241-B45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-319-67144-4_1","volume-title":"Rare Diseases Epidemiology: Update and Overview","author":"Groft","year":"2017"},{"key":"2025021811394227300_ocae241-B46","doi-asserted-by":"publisher","first-page":"867337","DOI":"10.3389\/fgene.2022.867337","article-title":"Population-based screening of newborns: findings from the NBS expansion study (part one)","volume":"13","author":"Brower","year":"2022","journal-title":"Front Genet"},{"issue":"1","key":"2025021811394227300_ocae241-B47","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13023-023-02669-7","article-title":"Psychological distress of adult patients consulting a center for rare and undiagnosed diseases: a cross-sectional study","volume":"18","author":"Mund","year":"2023","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2025021811394227300_ocae241-B48","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1186\/s12913-022-08060-9","article-title":"Mental health care for rare disease in the UK\u2014recommendations from a quantitative survey and multi-stakeholder workshop","volume":"22","author":"Spencer-Tansley","year":"2022","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"2025021811394227300_ocae241-B49","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s40359-021-00543-4","article-title":"Depression in adults with sickle cell disease: a systematic review of the methodological issues in assessing prevalence of depression","volume":"9","author":"Oudin Doglioni","year":"2021","journal-title":"BMC Psychol"},{"issue":"2","key":"2025021811394227300_ocae241-B50","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00127-022-02307-w","article-title":"Depression and anxiety prevalence in people with cystic fibrosis and their caregivers: a systematic review and meta-analysis","volume":"58","author":"Lord","year":"2023","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"2025021811394227300_ocae241-B51","doi-asserted-by":"publisher","first-page":"6708865","DOI":"10.1155\/2021\/6708865","article-title":"Global burden of anxiety and depression among cystic fibrosis patient: systematic review and meta-analysis","volume":"2021","author":"Guta","year":"2021","journal-title":"Int J Chronic Dis"},{"issue":"3","key":"2025021811394227300_ocae241-B52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/tropej\/fmac042","article-title":"Psychosocial impact of sickle cell disease and diabetes mellitus on affected children and their parents in Khartoum State, Sudan","volume":"68","author":"Yousif","year":"2022","journal-title":"J Trop Pediatr"},{"issue":"3","key":"2025021811394227300_ocae241-B53","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/IOP.0000000000002318","article-title":"Evaluation of depression and anxiety in a diverse population with thyroid eye disease using the nationwide NIH All of Us database","volume":"39","author":"Lee","year":"2023","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"2","key":"2025021811394227300_ocae241-B54","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/ajmg.a.63417","article-title":"A qualitative evaluation of patient and parent experiences with an undiagnosed diseases program","volume":"194","author":"Siebold","year":"2024","journal-title":"Am J Med Genet A"},{"issue":"1","key":"2025021811394227300_ocae241-B55","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41746-024-01038-3","article-title":"Leveraging generative AI to prioritize drug repurposing candidates for Alzheimer\u2019s disease with real-world clinical validation","volume":"7","author":"Yan","year":"2024","journal-title":"NPJ Digit Med"},{"author":"Every Cure","key":"2025021811394227300_ocae241-B56"},{"issue":"8003","key":"2025021811394227300_ocae241-B57","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41586-023-06957-x","article-title":"Genomic data in the All of Us Research Program","volume":"627","author":"The All of Us Research Program Genomics Investigators","year":"2024","journal-title":"Nature"},{"issue":"1","key":"2025021811394227300_ocae241-B58","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13073-022-01026-w","article-title":"A guide for the diagnosis of rare and undiagnosed disease: beyond the exome","volume":"14","author":"Marwaha","year":"2022","journal-title":"Genome Med"},{"year":"2024","author":"Research Program - Who Can Join?","key":"2025021811394227300_ocae241-B59"},{"year":"2024","author":"Research Program - FAQ","key":"2025021811394227300_ocae241-B60"},{"issue":"5","key":"2025021811394227300_ocae241-B61","doi-asserted-by":"publisher","first-page":"e181","DOI":"10.1016\/j.jaad.2023.12.059","article-title":"Enhancing study designs of disease prevalence investigations conducted with the All of Us Research Program","volume":"90","author":"Patil","year":"2024","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"2025021811394227300_ocae241-B62","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jaad.2023.09.076","article-title":"Prevalence of calcinosis cutis in the United States using the All of Us research database","volume":"90","author":"Kam","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"2025021811394227300_ocae241-B63","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jdin.2022.04.006","article-title":"Prevalence of pityriasis rosea in the United States: a cross-sectional study using the All of Us database","volume":"8","author":"Joshi","year":"2022","journal-title":"JAAD Int"},{"issue":"3","key":"2025021811394227300_ocae241-B64","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.jaad.2021.12.013","article-title":"Prevalence of lichen planus in the United States: a cross-sectional study of the All of Us research program","volume":"87","author":"Leasure","year":"2022","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Medical Informatics Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jamia\/article-pdf\/32\/3\/579\/61267851\/ocae241.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jamia\/article-pdf\/32\/3\/579\/61267851\/ocae241.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T11:40:02Z","timestamp":1739878802000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jamia\/article\/32\/3\/579\/7931701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,23]]},"references-count":64,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,12,23]]},"published-print":{"date-parts":[[2025,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jamia\/ocae241","relation":{},"ISSN":["1067-5027","1527-974X"],"issn-type":[{"type":"print","value":"1067-5027"},{"type":"electronic","value":"1527-974X"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2024,12,23]]}}}